62 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
be secured to fund those studies, and providing technology transfer, training and other support to be ready for clinical trial launch of RCS-01 and RCT
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
should partners be secured to fund those studies, and providing technology transfer, training and other support to be ready for clinical trial launch
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
of clinical studies in Japan for RCS-01 and RCT-01 should partners be secured to fund those studies, and (3) providing technology transfer, training
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
, training and other support to be ready for clinical trial launch of RCS-01 and RCT-01 in China with our partner, YOFOTO.
In combination with potential
20-F/A
jk2savl1k jbt3a78e27
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.2
65531rafhfu y344q
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.4
77czwa1954yx3foike
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.2
u8rddu2ax t1i3qs
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.2
bs95nqd2u6y jil
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.5
qhtk2sm 31b
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.3
qxnpqe9b
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.2
76u1 f06u8gju
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
pgzuhk 82rz8tb
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.3
7razhxq4
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
u0fack5f9yq 4t
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.2
cqxd8wfkh1nyklb j5p
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm